The $3bn deal with only one bank in the room

For one investment bank to run off with all the deal credit on a multibillion-dollar mandate is a rare thing indeed

Italian pharmaceuticals Rottapharm Madaus this week sold itself in a $3.1 billion deal without appointing an investment bank to the mandate, a move one City of London healthcare banker described as "scary".

Swedish pharma company Meda yesterday agreed the deal to acquire Rottapharm, which is owned by the Rovati family.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump